STARTUP PROFILE

Spinally

COUNTRY
Spain
FOUNDED
2022
CATEGORY
Neuromodulation
Developing FuturaLead, the world’s first intrathecal spinal cord stimulation (iSCS) lead, placed directly on the spinal cord surface, enabling superior efficacy and closed-loop neuromodulation via ECAP sensing.
Visit website →
Neurofounders Insights
$   Funding   -
Pre-seed
MODALITY
SCS
FORM FACTOR
Implant
INTERFACE DEPTH
Minimally invasive
INDICATION
Pain/migraine
TARGET USER
Patients
REGULATORY STAGE
Preclinical
Spinally is differentiated by its intrathecal spinal cord stimulation lead, which sits directly on the cord surface and aims to improve efficacy while enabling ECAP-based closed-loop control. This is a technically bold hardware innovation in a market otherwise dominated by incremental lead improvements.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Spinally
No items found.